The FDA announced on Feb. 12, 2015, that Apotex Inc. voluntarily recalled Bromfenac Ophthalmic Solution due to CGMP deviations involving untested product excipients, according to the FDA.
How to tell if you have it
- Brand: Apotex
- Product: Bromfenac Ophthalmic Solution 0.09%
- NDC: 60505-0595-5 (1.7 mL Bottle, Lot KY8498, Expiry 01/2016)
- NDC: 60505-0595-6 (2 x 1.7 mL Bottles, Lot KY8496, Expiry 01/2016)
- NDC: 60505-0596-4 (2.5 mL Bottles, Lots MC5426 and KZ2002, Expiries 02/2016 and 04/2016)
The hazard
The recall addresses CGMP deviations where the product excipient was not re-tested at the appropriate date, according to the FDA.
Context
GovInfoNow's records show Apotex Inc. has 19 other recalls on record since April 30, 2012. Other recent recalls of similar products include Apotex Metformin Tablets Recall (May 27, 2020), Apotex Atorvastatin 40mg Tablets Recall (Oct. 22, 2019), and Apotex Wal-Zan 150mg Tablets Recall (Sept. 24, 2019).